Perspective Therapeutics (CATX) Shares Outstanding (2010 - 2026)

Perspective Therapeutics has disclosed Shares Outstanding (Entity) across 17 years of filings, most recently posting $114.1 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 53.62% year-over-year to $114.1 million; the TTM figure through Jun 2026 stood at $114.1 million (up 53.62% YoY), while the FY2025 annual figure was $74.3 million, up 5.19% from the prior year.
• Shares Outstanding (Entity) came in at $114.1 million for Q2 2026 at Perspective Therapeutics, roughly flat from $114.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $114.1 million in Q2 2026 to a low of $14.2 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $53.0 million, with a median of $63.1 million recorded in 2024.
• Year-over-year, Shares Outstanding (Entity) gained 0.05% in 2022 and soared 156.75% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $14.2 million in 2022, then jumped by 98.3% to $28.2 million in 2023, then soared by 150.78% to $70.7 million in 2024, then grew by 5.19% to $74.3 million in 2025, then jumped by 53.47% to $114.1 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $114.1 million in Q2 2026, $114.0 million in Q1 2026, and $74.3 million in Q4 2025.